HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shoji Kubo Selected Research

Paraffin

5/2005Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: Immunohistochemical evidence.
5/2004A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker.
7/2002Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shoji Kubo Research Topics

Disease

96Hepatocellular Carcinoma (Hepatoma)
12/2023 - 04/2002
96Neoplasms (Cancer)
12/2023 - 06/2002
34Cholangiocarcinoma
04/2023 - 05/2004
30Fibrosis (Cirrhosis)
05/2022 - 04/2002
22Neoplasm Metastasis (Metastasis)
09/2023 - 03/2002
21Infections
08/2021 - 04/2002
18Hepatitis
01/2015 - 12/2002
11Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 05/2004
11Lymphatic Metastasis
03/2022 - 03/2002
9Hemorrhage
09/2023 - 03/2003
8Carcinoma (Carcinomatosis)
04/2023 - 07/2002
8Chronic Hepatitis C
10/2020 - 11/2005
7Liver Diseases (Liver Disease)
01/2021 - 08/2004
6Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2023 - 10/2014
6Carcinogenesis
12/2023 - 08/2005
5Inflammation (Inflammations)
12/2023 - 11/2004
5Liver Neoplasms (Liver Cancer)
01/2023 - 04/2015
5Liver Failure
12/2017 - 02/2004
5Margins of Excision
04/2014 - 03/2002
5Thrombosis (Thrombus)
09/2009 - 01/2002
4Pancreaticobiliary Maljunction
12/2022 - 03/2019
4Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 03/2003
4Surgical Wound Infection
07/2021 - 03/2013
4Adenocarcinoma
05/2020 - 05/2004
4Cholangitis
03/2019 - 06/2002
3Ascites
02/2023 - 07/2004
3Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 11/2018
3Wounds and Injuries (Trauma)
09/2021 - 01/2002
3Diabetes Mellitus
09/2021 - 07/2004
3Necrosis
01/2021 - 12/2006
3Rupture
04/2019 - 03/2003
3Hepatitis C
12/2014 - 01/2004
3Chronic Hepatitis B
01/2005 - 05/2002
3Cysts
12/2004 - 12/2003
3Pathologic Constriction (Stenosis)
05/2004 - 06/2002
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
05/2004 - 01/2003
2Portal Hypertension
12/2023 - 03/2003
2Varicose Veins (Varicose Vein)
12/2023 - 03/2003
2Fatigue
09/2023 - 01/2015
2Intraabdominal Infections
09/2023 - 05/2018
2Gallbladder Neoplasms (Gallbladder Cancer)
12/2022 - 01/2006

Drug/Important Bio-Agent (IBA)

18InterferonsIBA
01/2020 - 12/2002
12DNA (Deoxyribonucleic Acid)IBA
12/2014 - 01/2003
10CarbohydratesIBA
03/2022 - 01/2003
9propylene dichlorideIBA
04/2023 - 01/2014
9Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 03/2003
9Collagen Type IV (Type IV Collagen)IBA
12/2017 - 01/2003
9Anti-Infective Agents (Microbicides)IBA
12/2014 - 04/2005
8BilirubinIBA
10/2023 - 01/2003
8Indocyanine Green (Cardio-Green)FDA LinkGeneric
02/2023 - 04/2003
8SolventsIBA
04/2020 - 01/2014
7MicroRNAs (MicroRNA)IBA
12/2023 - 03/2013
7Antiviral Agents (Antivirals)IBA
12/2023 - 11/2012
7AlbuminsIBA
10/2023 - 10/2003
7Biomarkers (Surrogate Marker)IBA
05/2023 - 05/2004
7Methylene Chloride (Dichloromethane)IBA
04/2023 - 01/2014
7AntigensIBA
03/2022 - 01/2003
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2020 - 07/2002
6Serum AlbuminIBA
01/2021 - 07/2004
6gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
07/2016 - 01/2014
6Alanine Transaminase (SGPT)IBA
01/2014 - 07/2004
6Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2012 - 04/2003
5Keratin-19 (Keratin 19)IBA
02/2008 - 10/2003
4phytobacteriomycin (PBM)IBA
12/2022 - 03/2019
4Proteins (Proteins, Gene)FDA Link
12/2022 - 06/2002
4GemcitabineFDA Link
12/2021 - 10/2014
4Bile Pigments (Bilin)IBA
12/2020 - 01/2014
4Carcinoembryonic AntigenIBA
01/2020 - 03/2002
4Anti-Bacterial Agents (Antibiotics)IBA
10/2019 - 12/2003
4Aspartic Acid (Aspartate)FDA Link
03/2018 - 10/2004
3CarcinogensIBA
04/2023 - 01/2014
3Fetal Proteins (Fetoprotein)IBA
01/2023 - 10/2020
3pembrolizumabIBA
08/2022 - 03/2021
3Cysteine (L-Cysteine)FDA Link
05/2022 - 04/2015
3CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2020 - 02/2008
3Tumor Biomarkers (Tumor Markers)IBA
10/2019 - 12/2003
3Alanine (L-Alanine)FDA Link
03/2018 - 01/2003
3S-allylcysteine (allyl cysteine)IBA
05/2015 - 12/2009
3Vitamin K 2 (Vitamin K2)IBA
09/2007 - 04/2002
3ParaffinIBA
05/2005 - 07/2002
3Keratins (Keratin)IBA
05/2004 - 04/2002
2Metronidazole (Metric)FDA LinkGeneric
09/2023 - 05/2018
2Messenger RNA (mRNA)IBA
12/2022 - 11/2015

Therapy/Procedure

58Therapeutics
12/2023 - 01/2001
31Hepatectomy
10/2023 - 09/2003
14Drug Therapy (Chemotherapy)
10/2023 - 09/2002
12Liver Transplantation
10/2020 - 09/2003
10Laparotomy
01/2020 - 03/2002
9Radiofrequency Ablation
10/2023 - 01/2003
8Pancreaticoduodenectomy
09/2023 - 07/2002
7Lymph Node Excision (Lymph Node Dissection)
01/2022 - 05/2004
7Cholecystectomy
12/2020 - 01/2002
6Aftercare (After-Treatment)
01/2016 - 07/2002
5Segmental Mastectomy (Lumpectomy)
07/2022 - 11/2005
5Blood Transfusion (Blood Transfusions)
01/2018 - 07/2004
4Neoadjuvant Therapy
01/2022 - 07/2015
4Transplantation
12/2014 - 09/2003
3Operative Surgical Procedures
05/2022 - 10/2015
3Adjuvant Chemotherapy
01/2022 - 04/2014
3Length of Stay
02/2017 - 06/2003